Read + Share
Amedeo Smart
Independent Medical Education
Yang X, Chu X, Ye R, Ni J, et al. Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinib. Clin Exp Metastasis 2025;42:31.PMID: 40439915
Email
LinkedIn
Privacy Policy